ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Amyl Therapeutics raised €8.25 million in a Series A extension funding round. The financing supports the company's continued development efforts. The round adds to the company's existing Series A capital.
Tap to vote and see what everyone thinks.
Summary by ByteBrief